These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18511547)

  • 1. Measuring quality of care for rheumatic diseases using an electronic medical record.
    Agnew-Blais JC; Coblyn JS; Katz JN; Anderson RJ; Mehta J; Solomon DH
    Ann Rheum Dis; 2009 May; 68(5):680-4. PubMed ID: 18511547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Indicators for Evaluating the Health Care of Patients with Rheumatoid Arthritis: a Korean Expert Consensus.
    Seo MR; Kim G; Moon KW; Sung YK; Yoo JJ; Yoon CH; Lee EB; Lee J; Kang EH; Kim H; Park EJ; Uhm WS; Lee MS; Lee SW; Choi BY; Hong SJ; Baek HJ
    J Korean Med Sci; 2021 May; 36(17):e109. PubMed ID: 33942576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American College of Rheumatology quality indicators for rheumatoid arthritis: benchmarking, variability, and opportunities to improve quality of care using the electronic health record.
    Adhikesavan LG; Newman ED; Diehl MP; Wood GC; Bili A
    Arthritis Rheum; 2008 Dec; 59(12):1705-12. PubMed ID: 19035412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of American College of Rheumatology-Endorsed Quality Indicators in Rheumatoid Arthritis Patients: A Quality Improvement Initiative.
    Anderson E; Bajaj P; Raghavan S; Patnaik A; Roppelt H
    J Clin Rheumatol; 2016 Mar; 22(2):63-7. PubMed ID: 26906296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Electronic Medical Records in Community Rheumatology Practice for Assessing Quality of Care Indicators for Gout: A Feasibility Study.
    Estrada A; Tsao NW; Howren A; Esdaile JM; Shojania K; De Vera MA
    J Clin Rheumatol; 2018 Mar; 24(2):75-79. PubMed ID: 29232325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality indicators in rheumatoid arthritis: results from the METEOR database.
    Navarro-Compán V; Smolen JS; Huizinga TW; Landewé R; Ferraccioli G; da Silva JA; Moots RJ; Kay J; van der Heijde D
    Rheumatology (Oxford); 2015 Sep; 54(9):1630-9. PubMed ID: 25877910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing process of care in rheumatoid arthritis at McGill University hospitals.
    Li LM; Tessier-Cloutier B; Wang Y; Bernatsky S; Vinet E; Ménard HA; Panopalis P; Hazel E; Stein M; Cohen M; Starr M; Pineau C; Veilleux MÈ; Colmegna I
    J Clin Rheumatol; 2013 Jun; 19(4):175-9. PubMed ID: 23669798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care quality for rheumatoid arthritis patients in Quebec.
    Slim Z; Moura CS; Bernatsky S; Rahme E
    Int J Rheum Dis; 2019 Jul; 22(7):1233-1238. PubMed ID: 30993889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing trends in disease modifying antirheumatic drugs for rheumatoid arthritis: a survey of practicing Canadian rheumatologists.
    Pope JE; Hong P; Koehler BE
    J Rheumatol; 2002 Feb; 29(2):255-60. PubMed ID: 11838842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of care for gout in the US needs improvement.
    Singh JA; Hodges JS; Toscano JP; Asch SM
    Arthritis Rheum; 2007 Jun; 57(5):822-9. PubMed ID: 17530682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial disease modifying antirheumatic drugs and prednisolone prescriptions for patients with rheumatoid arthritis: a 15-year study.
    Osiri M; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2000 Mar; 83(3):217-24. PubMed ID: 10808674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can the adherence to quality of care indicators for early rheumatoid arthritis in clinical practice reduce risk of hospitalisation? Retrospective cohort study based on the Record Linkage of Rheumatic Disease study of the Italian Society for Rheumatology.
    Zanetti A; Scirè CA; Argnani L; Carrara G; Zambon A;
    BMJ Open; 2020 Sep; 10(9):e038295. PubMed ID: 32994247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Measurement and Adherence to System Performance Measures for Rheumatoid Arthritis in 5 Models of Care.
    Barber CEH; Thorne JC; Ahluwalia V; Burt J; Lacaille D; Marshall DA; Hazlewood GS; Mosher D; Denning L; Szamko I; Chin R; Hamilton S; Benseler S; Twilt M; Shiff NJ; Bykerk V; Homik J; Barnabe C
    J Rheumatol; 2018 Nov; 45(11):1501-1508. PubMed ID: 29907674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the initiation of disease-modifying antirheumatic drugs in newly diagnosed rheumatoid arthritis: a retrospective claims database study.
    Bonafede MM; Fox KM; Johnson BH; Watson C; Gandra SR
    Clin Ther; 2012 Feb; 34(2):457-67. PubMed ID: 22284901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing patients with information about disease-modifying anti-rheumatic drugs: Individually or in groups? A pilot randomized controlled trial comparing adherence and satisfaction.
    Homer D; Nightingale P; Jobanputra P
    Musculoskeletal Care; 2009 Jun; 7(2):78-92. PubMed ID: 18792423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of first-line biological treatment in patients with rheumatoid arthritis: Results from an observational study.
    Angelici L; Addis A; Agabiti N; Kirchmayer U; Davoli M; Belleudi V
    Medicine (Baltimore); 2021 May; 100(19):e25943. PubMed ID: 34106665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Population-Based Approach to Reporting System-Level Performance Measures for Rheumatoid Arthritis Care.
    Barber CEH; Marshall DA; Szefer E; Barnabe C; Shiff NJ; Bykerk V; Homik J; Thorne JC; Ahluwalia V; Benseler S; Mosher D; Twilt M; Lacaille D
    Arthritis Care Res (Hoboken); 2021 May; 73(5):640-648. PubMed ID: 32144843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology-Enabled Outreach to Patients Taking High-Risk Medications Reduces a Quality Gap in Completion of Clinical Laboratory Testing.
    Raebel MA; Shetterly SM; Bhardwaja B; Sterrett AT; Schroeder EB; Chorny J; Hagen TP; Silverman DJ; Astles R; Lubin IM
    Popul Health Manag; 2020 Feb; 23(1):3-11. PubMed ID: 31107176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(How) Are quality indicators for measuring and appraising the quality of healthcare derived from evidence-based clinical practice guidelines? A review].
    Deckert S; Steudtner M; Becker M; Brombach M; Neugebauer E; Nothacker M; Schmitt J
    Z Evid Fortbild Qual Gesundhwes; 2019 Nov; 147-148():45-57. PubMed ID: 31718988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.